Loss of ACK1 Upregulates EGFR and Mediates Resistance to BRAF Inhibition-Reference-Cited by-同舟云学术

Loss of ACK1 Upregulates EGFR and Mediates Resistance to BRAF Inhibition

Published:2021-05 Issue:5 Volume:141 Page:1317-1324.e1
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Ji Zhenyu^ORCID,Njauw Ching-Ni^ORCID,Guhan Samantha^ORCID,Kumar Raj^ORCID,Reddy Bobby,Rajadurai Anpuchelvi^ORCID,Flaherty Keith^ORCID,Tsao Hensin^ORCID

Funder

Melanoma Research Alliance

Massachusetts General Hospital

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference31 articles.

1. Overcoming resistance to BRAF inhibitors;Arozarena;Ann Transl Med,2017

2. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma;Bollag;Nature,2010

3. Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2;Chan;J Biol Chem,2009

4. EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib;Corcoran;Cancer Discov,2012

5. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib);Cell Communication and Signaling;2024-08-23

2. Liquid biopsy for diagnostic and prognostic evaluation of melanoma;Frontiers in Cell and Developmental Biology;2024-08-02

3. Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance;Cancers;2024-08-02

4. ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway;Biology Direct;2024-04-22

5. MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling;Molecular Cancer Therapeutics;2023-09-25